MYLI
Meiji Yasuda Life Insurance Portfolio holdings
AUM
$3.36B
1-Year Return
6.72%
This Quarter Return
+1.13%
1 Year Return
+6.72%
3 Year Return
+22.89%
5 Year Return
+12.46%
10 Year Return
+72.23%
AUM
$4.98B
AUM Growth
+$260M
(+5.5%)
Cap. Flow
+$243M
Cap. Flow
% of AUM
4.87%
Top 10 Holdings %
Top 10 Hldgs %
78.35%
Holding
278
New
18
Increased
81
Reduced
111
Closed
36
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$173M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$61.1M |
| 3 |
Boston Scientific
BSX
|
$9.8M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$8.55M |
| 5 |
Utilities Select Sector SPDR Fund
XLU
|
$7.86M |
Top Sells
| 1 |
Salesforce
CRM
|
$8.11M |
| 2 |
AbbVie
ABBV
|
$7.73M |
| 3 |
Microsoft
MSFT
|
$5.65M |
| 4 |
Abbott
ABT
|
$4.43M |
| 5 |
Apple
AAPL
|
$3.9M |
Sector Composition
| 1 | Technology | 8.46% |
| 2 | Healthcare | 3.13% |
| 3 | Financials | 3.08% |
| 4 | Consumer Discretionary | 2.55% |
| 5 | Communication Services | 2.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Jacobs Solutions
J
$17.4B
| $270K | 0.01% |
+2,333
| New | +$270K |
|
227
Starbucks
SBUX
$97.1B
| $268K | 0.01% |
3,437
-3,600
| -51% | -$280K |
|
228
Bristol-Myers Squibb
BMY
$96B
| $252K | 0.01% |
6,070
-46,006
| -88% | -$1.91M |
|
229
3M
MMM
$82.7B
| $250K | 0.01% |
2,451
-409
| -14% | -$41.8K |
|
230
Darling Ingredients
DAR
$5.07B
| $250K | 0.01% |
6,800
| – | – |
|
231
Huntington Ingalls Industries
HII
$10.6B
| $249K | 0.01% |
1,010
-2,190
| -68% | -$539K |
|
232
Omnicom Group
OMC
$15.4B
| $243K | ﹤0.01% |
2,710
| – | – |
|
233
Parker-Hannifin
PH
$96.1B
| $235K | ﹤0.01% |
+464
| New | +$235K |
|
234
NXP Semiconductors
NXPI
$57.2B
| $228K | ﹤0.01% |
846
-950
| -53% | -$256K |
|
235
Manhattan Associates
MANH
$13B
| $220K | ﹤0.01% |
+890
| New | +$220K |
|
236
Colgate-Palmolive
CL
$68.8B
| $219K | ﹤0.01% |
2,260
-140
| -6% | -$13.6K |
|
237
WEC Energy
WEC
$34.7B
| $218K | ﹤0.01% |
+2,784
| New | +$218K |
|
238
Gilead Sciences
GILD
$143B
| $217K | ﹤0.01% |
3,166
-43,909
| -93% | -$3.01M |
|
239
West Pharmaceutical
WST
$18B
| $217K | ﹤0.01% |
659
-670
| -50% | -$221K |
|
240
Illumina
ILMN
$15.7B
| $208K | ﹤0.01% |
1,992
-56
| -3% | -$5.85K |
|
241
Blackstone
BX
$133B
| $202K | ﹤0.01% |
+1,633
| New | +$202K |
|
242
Sherwin-Williams
SHW
$92.9B
| $201K | ﹤0.01% |
675
-2,480
| -79% | -$740K |
|
243
A.O. Smith
AOS
$10.3B
| – | – |
-3,800
| Closed | -$340K |
|
244
Cardinal Health
CAH
$35.7B
| – | – |
-7,931
| Closed | -$887K |
|
245
CDW
CDW
$22.2B
| – | – |
-2,101
| Closed | -$537K |
|
246
Cigna
CI
$81.5B
| – | – |
-3,700
| Closed | -$1.34M |
|
247
Clorox
CLX
$15.5B
| – | – |
-2,890
| Closed | -$442K |
|
248
Comcast
CMCSA
$125B
| – | – |
-17,396
| Closed | -$754K |
|
249
Capital One
COF
$142B
| – | – |
-1,788
| Closed | -$266K |
|
250
Cisco
CSCO
$264B
| – | – |
-4,606
| Closed | -$230K |
|